Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.

Sixten Borg; Ulf Persson; Kristina Allikmets; Karin Ericsson

doi:10.1016/j.clinthera.2006.11.013

Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.

Sixten Borg, Ulf Persson, Kristina Allikmets, Karin Ericsson

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1947-59
Journal	Clinical Therapeutics
Volume	28
Issue number	11
DOIs	https://doi.org/10.1016/j.clinthera.2006.11.013
Publication status	Published - 2006

Subject classification (UKÄ)

Pharmaceutical Sciences

Access to Document

10.1016/j.clinthera.2006.11.013

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17213015&dopt=Abstract

Cite this

Borg, S., Persson, U., Allikmets, K., & Ericsson, K. (2006). Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model. Clinical Therapeutics, 28(11), 1947-59. https://doi.org/10.1016/j.clinthera.2006.11.013

@article{acc0549ca8b14944ab39b43f1b82221c,

title = "Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.",

author = "Sixten Borg and Ulf Persson and Kristina Allikmets and Karin Ericsson",

year = "2006",

doi = "10.1016/j.clinthera.2006.11.013",

language = "English",

volume = "28",

pages = "1947--59",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Elsevier",

number = "11",

}

Borg, S, Persson, U, Allikmets, K & Ericsson, K 2006, 'Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.', Clinical Therapeutics, vol. 28, no. 11, pp. 1947-59. https://doi.org/10.1016/j.clinthera.2006.11.013

Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model. / Borg, Sixten; Persson, Ulf; Allikmets, Kristina et al.
In: Clinical Therapeutics, Vol. 28, No. 11, 2006, p. 1947-59.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.

AU - Borg, Sixten

AU - Persson, Ulf

AU - Allikmets, Kristina

AU - Ericsson, Karin

PY - 2006

Y1 - 2006

UR - https://www.scopus.com/pages/publications/33845967154

U2 - 10.1016/j.clinthera.2006.11.013

DO - 10.1016/j.clinthera.2006.11.013

M3 - Article

C2 - 17213015

SN - 0149-2918

VL - 28

SP - 1947

EP - 1959

JO - Clinical Therapeutics

JF - Clinical Therapeutics

IS - 11

ER -

Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.

Subject classification (UKÄ)

Access to Document

Other files and links

Cite this